(Q55075982)

Sebastian Ley

7

0 references

Annette Kopp-Schneider

Annette Kopp-Schneider

3

0 references

Hans-Ulrich Kauczor

10

Hans-Ulrich Kauczor

0 references

Michael Puderbach

2

Michael Puderbach

0 references

Monika Eichinger

11

Monika Eichinger

0 references

Jürgen Biederer

9

Jürgen Biederer

0 references

Mirjam Stahl

4

Mirjam Stahl

0 references

author name string

Eva Fritzsching

5

0 references

Olaf Sommerburg

6

0 references

Migle Sumkauskaite

8

0 references

Marcus A. Mall

American Journal of Respiratory and Critical Care Medicine

12

0 references

language of work or name

English

0 references

publication date

15 April 2014

0 references

published in

0 references

volume

189

0 references

issue

8

0 references

page(s)

956-965

0 references

cites work

Pathophysiology and Management of Pulmonary Infections in Cystic Fibrosis

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201309-1659OC

Structural airway abnormalities in infants and young children with cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201309-1659OC

High-resolution computed tomography imaging of airway disease in infants with cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201309-1659OC

Computed tomography reflects lower airway inflammation and tracks changes in early cystic fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201309-1659OC

Bronchiectasis in infants and preschool children diagnosed with cystic fibrosis after newborn screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201309-1659OC

Lung disease at diagnosis in infants with cystic fibrosis detected by newborn screening.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201309-1659OC

Progression of early structural lung disease in young children with cystic fibrosis assessed using CT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201309-1659OC

Preventive but not late amiloride therapy reduces morbidity and mortality of lung disease in betaENaC-overexpressing mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201309-1659OC

Future directions in early cystic fibrosis lung disease research: an NHLBI workshop report

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201309-1659OC

Progressive damage on high resolution computed tomography despite stable lung function in cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201309-1659OC

Changes in airway dimensions on computed tomography scans of children with cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201309-1659OC

Estimation of the radiation dose from thoracic CT scans in a cystic fibrosis population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201309-1659OC

Computed tomography and magnetic resonance imaging in cystic fibrosis lung disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201309-1659OC

Radiologic imaging in cystic fibrosis: cumulative effective dose and changing trends over 2 decades.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201309-1659OC

Magnetic resonance imaging of cystic fibrosis lung disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201309-1659OC

Assessment of morphological MRI for pulmonary changes in cystic fibrosis (CF) patients: comparison to thin-section CT and chest x-ray.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201309-1659OC

The Chrispin-Norman score in cystic fibrosis: doing away with the lateral view

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201309-1659OC

New clinical diagnostic procedures for cystic fibrosis in Europe

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201309-1659OC

Standards of care for patients with cystic fibrosis: a European consensus

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201309-1659OC

Effect of aerosolized recombinant human DNase on exacerbations of respiratory symptoms and on pulmonary function in patients with cystic fibrosis. The Pulmozyme Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201309-1659OC

Inhaled hypertonic saline in infants and children younger than 6 years with cystic fibrosis: the ISIS randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201309-1659OC

Increased airway epithelial Na+ absorption produces cystic fibrosis-like lung disease in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201309-1659OC

Airway surface dehydration in cystic fibrosis: pathogenesis and therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201309-1659OC

Hypertonic saline is effective in the prevention and treatment of mucus obstruction, but not airway inflammation, in mice with chronic obstructive lung disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201309-1659OC

Improved visualization of delayed perfusion in lung MRI.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201309-1659OC

Bronchopulmonary disease in children with cystic fibrosis after early or delayed diagnosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201309-1659OC

Correlation of six different cystic fibrosis chest radiograph scoring systems with clinical parameters

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201309-1659OC

Radiological and functional changes over 3 years in young children with cystic fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201309-1659OC

The sensitivity of lung disease surrogates in detecting chest CT abnormalities in children with cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201309-1659OC

Infection, inflammation, and lung function decline in infants with cystic fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201309-1659OC

Lung clearance index as an outcome measure for clinical trials in young children with cystic fibrosis. A pilot study using inhaled hypertonic saline

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201309-1659OC

Early intervention studies in infants and preschool children with cystic fibrosis: are we ready?

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201309-1659OC

Risk Factors for Bronchiectasis in Children with Cystic Fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201309-1659OC

Morphologic and functional scoring of cystic fibrosis lung disease using MRI

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201309-1659OC

CFTR Cl− channel function in native human colon correlates with the genotype and phenotype in cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201309-1659OC

Contrast-enhanced 3D MRI of lung perfusion in children with cystic fibrosis—initial results

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201309-1659OC

Proton MRI appearance of cystic fibrosis: Comparison to CT

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201309-1659OC

Lung Function in Infants with Cystic Fibrosis Diagnosed by Newborn Screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201309-1659OC